Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

6.8K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

6.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Positive Regulator Molecules02:39

Positive Regulator Molecules

7.1K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway.

Clinical immunology (Orlando, Fla.)·2022
Same author

Targeting mGlu1 Receptors in the Treatment of Motor and Cognitive Dysfunctions in Mice Modeling Type 1 Spinocerebellar Ataxia.

Cells·2022
Same author

Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2022
Same author

Chronic treatment with corticosterone increases the number of tyrosine hydroxylase-expressing cells within specific nuclei of the brainstem reticular formation.

Frontiers in neuroanatomy·2022
Same author

Gene Co-Expression Network Modular Analysis Reveals Altered Immune Mechanisms in HIV-HAND.

Brain sciences·2022
Same author

Ms. Rabia Moin: A Linchpin in the Road to Success of <i>Current Neuropharmacology</i>.

Current neuropharmacology·2022

Related Experiment Video

Updated: Apr 4, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

3.2K

Cyclin D1 and Ewing's sarcoma/PNET: A microarray analysis.

Paolo Fagone1, Ferdinando Nicoletti1, Lucia Salvatorelli2

  • 1Department of Biomedical Sciences, School of Medicine, University of Catania, Catania, Italy.

Acta Histochemica
|September 14, 2015
PubMed
Summary
This summary is machine-generated.

Cyclin D1 is highly expressed in Ewing sarcoma/peripheral neuroectodermal tumor (PNET) but not rhabdomyosarcoma. This finding supports cyclin D1 as a diagnostic marker and potential therapeutic target for pediatric sarcomas.

Keywords:
Bioinformatic analysisCyclin D1Ewing's sarcoma/peripheral primitive neuroectodermal tumorMicroarrayRhabdomyosarcoma

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

28.7K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Related Experiment Videos

Last Updated: Apr 4, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

3.2K
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

28.7K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Area of Science:

  • Oncology
  • Molecular Biology
  • Pediatric Pathology

Background:

  • Cyclin D1 expression was previously observed in pediatric soft tissue tumors.
  • Immunohistochemical analysis differentiated Ewing sarcoma/peripheral neuroectodermal tumor (PNET) from rhabdomyosarcoma based on cyclin D1.
  • Cyclin D1's role in pediatric sarcomas requires further investigation.

Purpose of the Study:

  • To investigate cyclin D1 expression in Ewing sarcoma/PNET using microarray analysis.
  • To compare cyclin D1 expression in Ewing sarcoma/PNET with normal tissues and rhabdomyosarcoma.
  • To identify novel diagnostic and prognostic markers correlated with cyclin D1 in pediatric tumors.

Main Methods:

  • Immunohistochemistry
  • Microarray analysis
  • Bioinformatic analysis

Main Results:

  • Microarray analysis confirmed significant cyclin D1 upregulation in Ewing sarcoma compared to normal tissues.
  • Overexpression of cyclin D1 was confirmed in Ewing sarcoma relative to rhabdomyosarcoma.
  • Bioinformatic analysis identified novel genes correlated with cyclin D1, potential markers for Ewing sarcoma/PNET.

Conclusions:

  • Cyclin D1 is a valuable diagnostic marker for Ewing sarcoma/PNET.
  • Cyclin D1 overexpression suggests its potential as a therapeutic target in Ewing sarcoma/PNET.
  • Further research into cyclin D1-correlated genes may yield new diagnostic and prognostic tools for pediatric sarcomas.